First Drug Approved Under New Scheme To Speed Access In Poorer Countries
Seven African Regulators Took Part In The Procedure
Switzerland’s medicines agency has cleared Ferring’s carbetocin for preventing uterine haemorrhage under the Marketing Authorization for Global Health Products (MAGHP) procedure, which is intended to accelerate the approval of new products in low- and middle-income countries.
